Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients

Julie Bertrand,1 Fabrice Caillol,1 Patrick Borentain,2 Jean-Luc Raoul,1 Laurent Heyries,2 Erwan Bories,1 Christian Pesenti,1 Jean-Philippe Ratone,2 Jean-Paul Bernard,2 René Gerolami,2 Marc Giovannini1 1Endoscopy Unit, Paoli Calmettes Institute, Marseille, France; 2Department of Hepato-Gas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bertr, J, Caillol F, Borentain P, Raoul JL, Heyries L, Bories E, Pesenti C, Ratone JP, Bernard JP, Gerolami R, Giovannini M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/57229c9e85a44a9f967fc243e5532527
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:57229c9e85a44a9f967fc243e5532527
record_format dspace
spelling oai:doaj.org-article:57229c9e85a44a9f967fc243e55325272021-12-02T06:01:47ZPercutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients1179-1535https://doaj.org/article/57229c9e85a44a9f967fc243e55325272015-05-01T00:00:00Zhttp://www.dovepress.com/percutaneous-hepatic-radiofrequency-for-hepatocellular-carcinoma-resul-peer-reviewed-article-HMERhttps://doaj.org/toc/1179-1535Julie Bertrand,1 Fabrice Caillol,1 Patrick Borentain,2 Jean-Luc Raoul,1 Laurent Heyries,2 Erwan Bories,1 Christian Pesenti,1 Jean-Philippe Ratone,2 Jean-Paul Bernard,2 René Gerolami,2 Marc Giovannini1 1Endoscopy Unit, Paoli Calmettes Institute, Marseille, France; 2Department of Hepato-Gastroenterology, Conception Hospital, Marseille, France Abstract: Radiofrequency ablation (RFA) is a curative option for hepatocellular carcinoma (HCC), the most common primary malignancy of the liver. This bicentric retrospective study includes 46 patients admitted for their first percutaneous RFA for HCC. Sixty-three nodules were treated, with an average size of 32.5 mm. Our study confirms the efficiency of this technique for attaining necrosis of HCC nodules, with few complications. Subgroup studies according to RFA mode (mono- or multipolar), etiology of cirrhosis (alcoholic or viral), and HCC size showed better efficiency for multipolar RFA when applied to small tumors and better survival when the cirrhosis was due to viral infection. However, we noted a high rate of local recurrence in our and other recent works compared to previous studies, probably due to improved imaging techniques. The main problem is still de novo intrahepatic recurrence in diseased livers. Keywords: radiofrequency ablation, cirrhosis, HCCBertrJCaillol FBorentain PRaoul JLHeyries LBories EPesenti CRatone JPBernard JPGerolami RGiovannini MDove Medical PressarticleDiseases of the digestive system. GastroenterologyRC799-869ENHepatic Medicine: Evidence and Research, Vol 2015, Iss default, Pp 21-27 (2015)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle Diseases of the digestive system. Gastroenterology
RC799-869
Bertr
J
Caillol F
Borentain P
Raoul JL
Heyries L
Bories E
Pesenti C
Ratone JP
Bernard JP
Gerolami R
Giovannini M
Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
description Julie Bertrand,1 Fabrice Caillol,1 Patrick Borentain,2 Jean-Luc Raoul,1 Laurent Heyries,2 Erwan Bories,1 Christian Pesenti,1 Jean-Philippe Ratone,2 Jean-Paul Bernard,2 René Gerolami,2 Marc Giovannini1 1Endoscopy Unit, Paoli Calmettes Institute, Marseille, France; 2Department of Hepato-Gastroenterology, Conception Hospital, Marseille, France Abstract: Radiofrequency ablation (RFA) is a curative option for hepatocellular carcinoma (HCC), the most common primary malignancy of the liver. This bicentric retrospective study includes 46 patients admitted for their first percutaneous RFA for HCC. Sixty-three nodules were treated, with an average size of 32.5 mm. Our study confirms the efficiency of this technique for attaining necrosis of HCC nodules, with few complications. Subgroup studies according to RFA mode (mono- or multipolar), etiology of cirrhosis (alcoholic or viral), and HCC size showed better efficiency for multipolar RFA when applied to small tumors and better survival when the cirrhosis was due to viral infection. However, we noted a high rate of local recurrence in our and other recent works compared to previous studies, probably due to improved imaging techniques. The main problem is still de novo intrahepatic recurrence in diseased livers. Keywords: radiofrequency ablation, cirrhosis, HCC
format article
author Bertr
J
Caillol F
Borentain P
Raoul JL
Heyries L
Bories E
Pesenti C
Ratone JP
Bernard JP
Gerolami R
Giovannini M
author_facet Bertr
J
Caillol F
Borentain P
Raoul JL
Heyries L
Bories E
Pesenti C
Ratone JP
Bernard JP
Gerolami R
Giovannini M
author_sort Bertr
title Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
title_short Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
title_full Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
title_fullStr Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
title_full_unstemmed Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
title_sort percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/57229c9e85a44a9f967fc243e5532527
work_keys_str_mv AT bertr percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT j percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT caillolf percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT borentainp percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT raouljl percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT heyriesl percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT boriese percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT pesentic percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT ratonejp percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT bernardjp percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT gerolamir percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
AT giovanninim percutaneoushepaticradiofrequencyforhepatocellularcarcinomaresultsandoutcomeof46patients
_version_ 1718400111149580288